NextCure Ownership | Who Owns NextCure?

NextCure Ownership Summary

NextCure is owned by 32.68% institutional investors, 8.65% insiders, and 58.68% retail investors. Affinity asset advisors is the largest institutional shareholder, holding 6.90% of NXTC shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 3.03% of its assets in NextCure shares.

NXTC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NextCure	32.68%	8.65%	58.68%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Affinity asset advisors	241.83K	6.90%	$2.58M
Ikarian capital	238.30K	6.80%	$2.51M
Sofinnova investments	222.65K	6.35%	$2.38M
Pfizer	153.35K	4.37%	$1.54M
Blackrock	761.18K	2.73%	$1.21M
Boothbay fund management	69.62K	1.99%	$743.51K
Renaissance	60.53K	1.73%	$646.50K
Verdad advisers, lp	42.95K	1.23%	$458.76K
Geode capital management	31.09K	0.89%	$327.14K
Blackrock funding, inc. /de	27.79K	0.79%	$296.83K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pfizer	153.35K	0.64%	$1.54M
Verdad advisers, lp	42.95K	0.52%	$458.76K
Ikarian capital	238.30K	0.20%	$2.51M
Affinity asset advisors	241.83K	0.13%	$2.58M
Sofinnova investments	222.65K	0.09%	$2.38M
Cardiff park advisors	21.83K	0.02%	$233.18K
Boothbay fund management	69.62K	0.01%	$743.51K
Renaissance	60.53K	0.00%	$646.50K
Acadian asset management	18.98K	0.00%	$199.00K
Marshall wace, llp	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	48.19K	-	48.19K
Verdad advisers, lp	42.95K	0.52%	42.95K
Renaissance	60.53K	0.00%	26.90K
Vanguard fiduciary trust	16.02K	-	16.02K
Geode capital management	31.09K	-	7.93K

Top Sellers

Holder	Shares	% Assets	Change
Logos global management lp	-	-	-2.50M
Orbimed advisors	-	-	-1.14M
Vanguard group	-	-	-872.02K
Cable car capital	-	-	-758.14K
Tang capital management	-	-	-404.14K

New Positions

Holder	Shares	% Assets	Change	Value
Susquehanna group, llp	48.19K	-	48.19K	$37.15K
Verdad advisers, lp	42.95K	0.52%	42.95K	$458.76K
Vanguard fiduciary trust	16.02K	-	16.02K	$168.48K
Royal bank of canada	403.00	-	403.00	$1.00K

Sold Out

Holder	Change
Citigroup	-1.00
Qube research	-48.00
Advisor group	-1.19K
Tower research capital llc (trc)	-1.53K
Wells fargo & company/mn	-2.16K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	30	15.38%	1,735,135	-20.02%	32	1.91%	19	90.00%	5	25.00%
Mar 31, 2026	26	8.33%	2,169,454	14.33%	61	2.11%	10	-28.57%	4	33.33%
Dec 31, 2025	24	41.18%	1,897,561	121.14%	54	5.26%	14	-	3	-81.25%
Sep 30, 2025	1	-96.55%	21,833	-99.79%	-	0.07%	-	-100.00%	1	-88.89%
Jun 30, 2025	30	-23.08%	10,546,766	-31.36%	37	1.23%	8	-20.00%	10	11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Morn Total Stk Mkt Idx Investor	123.28K	3.03%	-
Vanguard Total Stock Mkt Idx Inv	123.28K	3.03%	-
Vanguard MStar Total Stk Mkt Idx Invest	123.28K	2.69%	-
Vanguard US Total Market Shares ETF	613.83K	2.19%	-
Federated Hermes MDT Small Cap Growth IS	315.18K	1.12%	-
Federated Hermes MDT SCG Institutional	315.18K	1.12%	-
Vanguard Institutional Extnd Mkt Idx Tr	33.57K	0.73%	-
BlackRock Advantage Small Cap Core Instl	169.79K	0.61%	-
Delaware Healthcare I	150.00K	0.54%	-
Macquarie Healthcare I	12.50K	0.47%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 10, 2026	Simcere Zaiming, Inc.	Former 10% Owner	Sell	$184.80K
Jul 30, 2026	ADAR1 Capital Management, LLC	-	Buy	$385.79K
Jul 31, 2026	ADAR1 Capital Management, LLC	-	Buy	$38.41K
Jul 31, 2026	ADAR1 Capital Management, LLC	-	Buy	$124.54K
Jul 31, 2026	ADAR1 Capital Management, LLC	-	Buy	$16.42K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	13	1
2026 Q2	-	-
2026 Q1	-	-
2025 Q2	-	-
2025 Q1	-	-

NXTC Ownership FAQ

Who Owns NextCure?

NextCure shareholders are primarily institutional investors at 32.68%, followed by 8.65% insiders and 58.67% retail investors. The average institutional ownership in NextCure's industry, Biotech Stocks , is 379.01%, which NextCure falls below.

Who owns the most shares of NextCure?

NextCure’s largest shareholders are Affinity asset advisors (241.83K shares, 6.90%), Ikarian capital (238.3K shares, 6.80%), and Sofinnova investments (222.65K shares, 6.35%). Together, they hold 20.05% of NextCure’s total shares outstanding.

Does Blackrock own NextCure?

Yes, BlackRock owns 2.73% of NextCure, totaling 761.18K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.21M$. In the last quarter, BlackRock decreased its holdings by -154 shares, a -0.02% change.

Who is NextCure’s biggest shareholder by percentage of total assets invested?

Pfizer is NextCure’s biggest shareholder by percentage of total assets invested, with 0.64% of its assets in 153.35K NextCure shares, valued at 1.54M$.

Who is the top mutual fund holder of NextCure shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of NextCure shares, with 3.03% of its total shares outstanding invested in 123.28K NextCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools